Lyell Immunopharma (LYEL) EBIT Margin Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3,724.00 |
| 10 | Lyell Immunopharma | 379.11 Mn | 379.11 Mn | - | -139.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -139.35 Mn |
| Dec 31, 2025 | -29.88 Mn |
| Sep 30, 2025 | -9.98 Mn |
| Jun 30, 2025 | -19.29 Mn |
| Mar 31, 2025 | 103.30 Mn |
| Dec 31, 2024 | -137.09 Mn |
| Sep 30, 2024 | 8.76 Mn |
| Jun 30, 2024 | -15.23 Mn |
| Mar 31, 2024 | -175.63 Mn |
| Dec 31, 2023 | -45.77 Mn |
| Sep 30, 2023 | 197.84 Mn |
| Jun 30, 2023 | -24.40 Mn |
| Mar 31, 2023 | -8.38 Mn |
| Dec 31, 2022 | 165,400.00 |
| Sep 30, 2022 | -221.28 Mn |
| Jun 30, 2022 | 228,186.00 |
| Mar 31, 2022 | -1.01 Mn |
| Dec 31, 2021 | 2,497.00 |
| Sep 30, 2021 | 165,884.00 |
| Jun 30, 2021 | 90,337.00 |